Targeting Chronic Lymphocytic Leukemia Using Cigb-300, a Clinical-Stage Ck2-Specific Cell-Permeable Peptide Inhibitor
AuthID
P-009-5HR
P-009-5HR
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service